APA (7th ed.) Citation

Sun, D., Zhang, X., Jin, X., Shi, C., Sun, Y., Zhang, Y., . . . Lin, Y. (2025). BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: A retrospective analysis of registered clinical trials. Thyroid Research, 18(1), 1. https://doi.org/10.1186/s13044-025-00223-0

Chicago Style (17th ed.) Citation

Sun, Di, Xin Zhang, Xiaona Jin, Cong Shi, Yuqing Sun, Yingqiang Zhang, Jun Liang, and Yansong Lin. "BRAFV600E Mutation Is Associated with Better Prognoses in Radioactive Iodine Refractory Thyroid Cancer Patients Treated with Multi-kinase Inhibitors: A Retrospective Analysis of Registered Clinical Trials." Thyroid Research 18, no. 1 (2025): 1. https://doi.org/10.1186/s13044-025-00223-0.

MLA (9th ed.) Citation

Sun, Di, et al. "BRAFV600E Mutation Is Associated with Better Prognoses in Radioactive Iodine Refractory Thyroid Cancer Patients Treated with Multi-kinase Inhibitors: A Retrospective Analysis of Registered Clinical Trials." Thyroid Research, vol. 18, no. 1, 2025, p. 1, https://doi.org/10.1186/s13044-025-00223-0.